logo

TYRA

Tyra Biosciences·NASDAQ
--
--(--)
--
--(--)
4.46 / 10
Netural

Analyst sentiment is overwhelmingly bullish with 25% Strong Buy and 75% Buy ratings, though historical win rates for these predictions are low (0.0% to 100%, average 1.10 weighted rating). Fund-flow analysis shows a 7.83/10 score with positive Small, Medium, and Large inflows, but overall and block flows are negative. This combination implies institutional caution versus retail/liquidity support, creating a mixed yet slightly bullish liquidity picture.

FundamentalSentiment(4.46)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

25%

Buy

75%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-23
InstitutionPiper Sandler
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for TYRA?
  • TYRA holds a Bearish analyst rating, with 75% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.46/10 (Netural).